Corporation is extending its groundbreaking MindBody GLP-1 System to international markets. This expansion comes after a 49% ...
Lake Street analyst Brooks O’Neil maintained a Buy rating on LifeVantage (LFVN – Research Report) today and set a price target of $30.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback